They reported that DNA methylation abnormalities were discrete in the early phase of CP and increased in the BC (around 0.3% of abnormally methylated CpG sites analyzed in CP, 1% in AP, and 2% in BC) (see Section 3.2). Here, CP is linked to breast cancer.